bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplemental Table 1 from Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)
Authors: Sinicrope Frank A. , Mahoney Michelle R. , Yoon Harry H. , Smyrk Thomas C. , Thibodeau Stephen N. , Goldberg Richard M. , Nelson Garth D. , Sargent Daniel J. , Alberts Steven R.
Published: April 2023

Supplemental Table 1. Univariate Cox Proportional Hazards Regression Models for Clinical Factors and Biomarkers (TTR, DFS, and OS)
Table S1 from Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma
Authors: Gordon Renata E. , Zhang Li , Peri Suraj , Kuo Yin-Ming , Du Fang , Egleston Brian L. , Ng Jessica M. Y. , Andrews Andrew J. , Astsaturov Igor , Curran Tom , Yang Zeng-Jie
Published: April 2023

Gene sets and pathways with selective enrichment among MB subtypes
Figure S3 from Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma
Authors: Gordon Renata E. , Zhang Li , Peri Suraj , Kuo Yin-Ming , Du Fang , Egleston Brian L. , Ng Jessica M. Y. , Andrews Andrew J. , Astsaturov Igor , Curran Tom , Yang Zeng-Jie
Published: April 2023

Simvastatin inhibits MB cell proliferation in Ptch1+/- mice.
Supplementary Table 4 from Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients
Authors: Parra Edwin R. , Behrens Carmen , Rodriguez-Canales Jaime , Lin Heather , Mino Barbara , Blando Jorge , Zhang Jianjun , Gibbons Don L. , Heymach John V. , Sepesi Boris , Swisher Stephen G. , Weissferdt Annikka , Kalhor Neda , Izzo Julie , Kadara Humam , Moran Cesar , Lee Jack J. , Wistuba Ignacio I.
Published: April 2023

Correlation between median PD-L1 H-score in macrophages and TAIC density by mm2 in the intratumoral and peritumoral compartments in lung ADC and SqCC specimens.
Figure S2 from Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma
Authors: Gordon Renata E. , Zhang Li , Peri Suraj , Kuo Yin-Ming , Du Fang , Egleston Brian L. , Ng Jessica M. Y. , Andrews Andrew J. , Astsaturov Igor , Curran Tom , Yang Zeng-Jie
Published: April 2023

Proliferation of MB cells does not rely on astrocyte-derived cholesterol
Supplementary Table 2 from Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients
Authors: Parra Edwin R. , Behrens Carmen , Rodriguez-Canales Jaime , Lin Heather , Mino Barbara , Blando Jorge , Zhang Jianjun , Gibbons Don L. , Heymach John V. , Sepesi Boris , Swisher Stephen G. , Weissferdt Annikka , Kalhor Neda , Izzo Julie , Kadara Humam , Moran Cesar , Lee Jack J. , Wistuba Ignacio I.
Published: April 2023

Median TAIC density by mm2 in the intratumoral and peritumoral compartments of lung ADC and SqCC specimens.
Supplementary Figure S1 from Global Hypomethylation (LINE-1) and Gene-Specific Hypermethylation (GSTP1) on Initial Negative Prostate Biopsy as Markers of Prostate Cancer on a Rebiopsy
Authors: Zelic Renata , Fiano Valentina , Zugna Daniela , Grasso Chiara , Delsedime Luisa , Daniele Lorenzo , Galliano Diego , Pettersson Andreas , Gillio-Tos Anna , Merletti Franco , Richiardi Lorenzo
Published: April 2023

Kernel density estimate of LINE-1 methylation distribution in biopsies vs. transurethral resection of the prostate (TURP) in the Ward 1 and Ward 2 combined. Cases and controls are presented separately.
Supplemental Figure 1 from A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma
Authors: Galloway Thomas J. , Wirth Lori J. , Colevas Alexander D. , Gilbert Jill , Bauman Julie E. , Saba Nabil F. , Raben David , Mehra Ranee , Ma Anna W. , Atoyan Ruzanna , Wang Jing , Burtness Barbara , Jimeno Antonio
Published: April 2023

Supplemental Figure 1. Pharmacodynamic effects of CUDC-101 in tumor, skin and PBMCs.
Supplemental Figure 1 from KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib
Authors: Nilsson Monique B. , Giri Uma , Gudikote Jayanthi , Tang Ximing , Lu Wei , Tran Hai , Fan Youhong , Koo Andrew , Diao Lixia , Tong Pan , Wang Jing , Herbst Roy , Johnson Bruce E. , Ryan Andy , Webster Alan , Rowe Philip , Wistuba Ignacio I. , Heymach John V.
Published: April 2023

Supplemental Figure 1. (A) Calu-1 cells were treated with VEGF (50 ng/ml) for 15 minutes and phospho-p38 levels were evaluated by Western blotting. VEGF treatment resulted in activation of p38, and this was blocked with the addition of VEGFR TKIs axitinib or sorafenib. (B) A549, H23, and Calu-1 cells express minimal levels of VEGFR1 as determined by ELISA assay. SKNAS neuroblastoma cells serve as a positive control.
Supplemental Figure S1 from Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma
Authors: Lamora Audrey , Talbot Julie , Bougras Gwenola , Amiaud Jérôme , Leduc Marion , Chesneau Julie , Taurelle Julien , Stresing Verena , Le Deley Marie Cécile , Heymann Marie Françoise , Heymann Dominique , Redini Françoise , Verrecchia Franck
Published: April 2023

This supplementary figure demonstrates that Smad7 and SD-208 inhibit the Smad3 signaling pathway in SAOS2 cells and that Smad7 does not inhibit the MAPK pathway in response to TGF-β.
Supplementary tables S1-S10 from KEAP1 Genetic Polymorphisms Associate with Breast Cancer Risk and Survival Outcomes
Authors: Hartikainen Jaana M. , Tengström Maria , Winqvist Robert , Jukkola-Vuorinen Arja , Pylkäs Katri , Kosma Veli-Matti , Soini Ylermi , Mannermaa Arto
Published: April 2023

Supplementary tables S1-S10. S1. Significant associations of the KEAP1 protein expression and receptor statuses; S2. Association of the KEAP1 protein expression with NRF2 protein expression; S3. Analyzed polymorphisms in the KEAP1 gene; S4. Significant associations of the KEAP1 SNP genotypes with KEAP1 protein expression; S5. Associations of the KEAP1 SNP s11085735 genotypes with NRF2 protein expression; S6. Associations of the KEAP1 SNPs with breast cancer survival in multivariate analysis among invasive KBCP and OBCS breast cancer cases separately; S7. Variables significantly associated with breast cancer survival in multivariate analysis among invasive KBCP and OBCS breast cancer cases; S8. Significant associations with breast cancer survival in univariate analysis (Kaplan-Meier) according to KEAP1 SNP rs11085735 genotypes among KBCP and OBCS ER positive cases, KBCP ER positive cases and KBCP cases with low/negative ({less than or equal to}1.33) KEAP1 protein expression levelS9. Variables significantly associated with breast cancer survival in multivariate analysis among ER positive KBCP breast cancer cases; S10. Variables significantly associated with breast cancer survival in multivariate analysis among (KBCP) cases with lower KEAP1 protein expression
Supplemental Table and Figure Legends from Clinical Application of Prognostic Gene Expression Signature in Fusion Gene–Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group
Authors: Hingorani Pooja , Missiaglia Edoardo , Shipley Janet , Anderson James R. , Triche Timothy J. , Delorenzi Mauro , Gastier-Foster Julie , Wing Michele , Hawkins Douglas S. , Skapek Stephen X.
Published: April 2023

Contains Supplemental Table 1 showing the target sequences used for the 5 genes and Supplementary Figure Legends
Supplementary Figure 1 from FGFR1/3 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Non–Small Cell Lung Cancer
Authors: Wang Rui , Wang Lei , Li Yuan , Hu Haichuan , Shen Lei , Shen Xuxia , Pan Yunjian , Ye Ting , Zhang Yang , Luo Xiaoyang , Zhang Yiliang , Pan Bin , Li Bin , Li Hang , Zhang Jie , Pao William , Ji Hongbin , Sun Yihua , Chen Haiquan
Published: April 2023

FGFR3-TACC3 fusion variants and BAG4-FGFR1 fusion in NSCLCs
Supplementary Figures S1-S13 from Loss-of-Function Mutations in Calcitonin Receptor (CALCR) Identify Highly Aggressive Glioblastoma with Poor Outcome
Authors: Pal Jagriti , Patil Vikas , Kumar Anupam , Kaur Kavneet , Sarkar Chitra , Somasundaram Kumaravel
Published: April 2023

Supplementary Figures S1-S13
Supplementary Appendix from A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer
Authors: Pandit-Taskar Neeta , O'Donoghue Joseph A. , Durack Jeremy C. , Lyashchenko Serge K. , Cheal Sarah M. , Beylergil Volkan , Lefkowitz Robert A. , Carrasquillo Jorge A. , Martinez Danny F. , Fung Alex Mak , Solomon Stephen B. , Gönen Mithat , Heller Glenn , Loda Massimo , Nanus David M. , Tagawa Scott T. , Feldman Jarett L. , Osborne Joseph R. , Lewis Jason S. , Reuter Victor E. , Weber Wolfgang A. , Bander Neil H. , Scher Howard I. , Larson Steven M. , Morris Michael J.
Published: April 2023

Supplementary Appendix
Supplementary Table 3 from Circulating Tumor Cell Analysis in Metastatic Triple-Negative Breast Cancers
Authors: Magbanua Mark Jesus M. , Carey Lisa A. , DeLuca Amy , Hwang Jimmy , Scott Janet H. , Rimawi Mothaffar F. , Mayer Erica L. , Marcom P. Kelly , Liu Minetta C. , Esteva Francisco J. , Park John W. , Rugo Hope S.
Published: April 2023

Supplementary Table 3. Proportional hazard Cox multivariate regression models to estimate risk of progression or death for dichotomized groups based on predefined cutoffs for CellSearch and IE/FC circulating tumor cell (CTC) enumeration at different time points. Multivariate Cox models with the dichotomized CellSearch and IE/FC groups using various cutoffs were used to estimate hazard ratios to compare prognostic value with respect to TTP or OS. For TTP assessment, Models #1 and #3 showed that only CTC numbers obtained via CellSearch using the cutoff of {greater than or equal to}1 CTC/mL at 7-14d approached significance (p<0.08, HR=2.1). Similar results were obtained for Models #1 and #3 when OS was assessed. Model #2 revealed borderline significance for CTC numbers obtained at 7-14d via CellSearch using the cutoff {greater than or equal to}5 CTC/7.5mL (p=0.06; HR=2.1). Model #4 also showed borderline significance for CTC numbers obtained at baseline via CellSearch using the cutoff {greater than or equal to}5 CTC/7.5mL (p=0.07; HR=2.1).
Supplementary Figures 1-6 from Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets
Authors: Rekhtman Natasha , Pietanza Maria C. , Hellmann Matthew D. , Naidoo Jarushka , Arora Arshi , Won Helen , Halpenny Darragh F. , Wang Hangjun , Tian Shaozhou K. , Litvak Anya M. , Paik Paul K. , Drilon Alexander E. , Socci Nicholas , Poirier John T. , Shen Ronglai , Berger Michael F. , Moreira Andre L. , Travis William D. , Rudin Charles M. , Ladanyi Marc
Published: April 2023

Supplementary Figure 1: Example of KRAS-mutated LCNEC: Illustration of NGS and histopathologic features; Supplementary Figure 2: Dot plots for total number of genomic alterations in carcinoid-like vs other LCNECs; Supplementary Figure 3: OncoPrints for chromatin modifier, neurogenesis/neural function, DNA replication/repair and PI3K-AKT-mTOR pathway genes; Supplementary Figure 4: Map of NOTCH mutations; Supplementary Figure 5: Expression of NE genes in transcriptional subgroups of lung adenocarcinoma in TCGA series; Supplementary Figure 6: Kaplan-Meier survival curves
Figure S3 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
Authors: Oizel Kristell , Chauvin Cynthia , Oliver Lisa , Gratas Catherine , Geraldo Fanny , Jarry Ulrich , Scotet Emmanuel , Rabe Marion , Alves-Guerra Marie-Clotilde , Teusan Raluca , Gautier Fabien , Loussouarn Delphine , Compan Vincent , Martinou Jean-Claude , Vallette François M. , Pecqueur Claire
Published: April 2023

RNA levels of metabolic enzymes and c-MYC
Figure S1 from Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity
Authors: Oizel Kristell , Chauvin Cynthia , Oliver Lisa , Gratas Catherine , Geraldo Fanny , Jarry Ulrich , Scotet Emmanuel , Rabe Marion , Alves-Guerra Marie-Clotilde , Teusan Raluca , Gautier Fabien , Loussouarn Delphine , Compan Vincent , Martinou Jean-Claude , Vallette François M. , Pecqueur Claire
Published: April 2023

Morphology of primary cGBM cultures
Supplementary Table 1 from Head and Neck Squamous Cell Carcinomas Are Characterized by a Stable Immune Signature Within the Primary Tumor Over Time and Space
Authors: Wood Oliver , Clarke James , Woo Jeongmin , Mirza Adal H. , Woelk Christopher H. , Thomas Gareth J. , Vijayanand Pandurangan , King Emma , Ottensmeier Christian H.
Published: April 2023

Supplementary Table 1. Clinical Information from the cohort analyzed.
Supplementary methods from KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer
Authors: Lal Neeraj , White Brian S. , Goussous Ghaleb , Pickles Oliver , Mason Mike J. , Beggs Andrew D. , Taniere Philippe , Willcox Benjamin E. , Guinney Justin , Middleton Gary W.
Published: April 2023

Supplementary methods
Figure S8 from KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer
Authors: Lal Neeraj , White Brian S. , Goussous Ghaleb , Pickles Oliver , Mason Mike J. , Beggs Andrew D. , Taniere Philippe , Willcox Benjamin E. , Guinney Justin , Middleton Gary W.
Published: April 2023

KRAS MT CMS2 tumours are associated with reduced expression of STAT1 and CXCL10.
Figure S2 from KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer
Authors: Lal Neeraj , White Brian S. , Goussous Ghaleb , Pickles Oliver , Mason Mike J. , Beggs Andrew D. , Taniere Philippe , Willcox Benjamin E. , Guinney Justin , Middleton Gary W.
Published: April 2023

Antibody validation and staining.
Figure S1 from KRAS Mutation and Consensus Molecular Subtypes 2 and 3 Are Independently Associated with Reduced Immune Infiltration and Reactivity in Colorectal Cancer
Authors: Lal Neeraj , White Brian S. , Goussous Ghaleb , Pickles Oliver , Mason Mike J. , Beggs Andrew D. , Taniere Philippe , Willcox Benjamin E. , Guinney Justin , Middleton Gary W.
Published: April 2023

Immunohistochemistry algorithms.
Supplementary table and figure legends from Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma
Authors: Iida Yuuki , Ciechanover Aaron , Marzese Diego M. , Hata Keisuke , Bustos Matias , Ono Shigeshi , Wang Jinhua , Salomon Matthew P. , Tran Kevin , Lam Stella , Hsu Sandy , Nelson Nellie , Kravtsova-Ivantsiv Yelena , Mills Gordon B. , Davies Michael A. , Hoon Dave S.B.
Published: April 2023

The file contains Supplementary Table S1 and figure legends for Supplementary Figure S1 to S4
Supplementary Materials- figure legends from Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study
Authors: Hekman Marlène C.H. , Boerman Otto C. , de Weijert Mirjam , Bos Desirée L. , Oosterwijk Egbert , Langenhuijsen Hans F. , Mulders Peter F.A. , Rijpkema Mark
Published: April 2023

Supplementary Materials- figure legends
Supplemental Material Description from Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts
Authors: Sharma Priyanka , López-Tarruella Sara , García-Saenz Jose Angel , Ward Claire , Connor Carol S. , Gómez Henry L. , Prat Aleix , Moreno Fernando , Jerez-Gilarranz Yolanda , Barnadas Augusti , Picornell Antoni C. , del Monte-Millán Maria , Gonzalez-Rivera Milagros , Massarrah Tatiana , Pelaez-Lorenzo Beatriz , Palomero María Isabel , González del Val Ricardo , Cortes Javier , Fuentes Rivera Hugo , Bretel Morales Denisse , Márquez-Rodas Iván , Perou Charles M. , Wagner Jamie L. , Mammen Joshua M.V. , McGinness Marilee K. , Klemp Jennifer R. , Amin Amanda L. , Fabian Carol J. , Heldstab Jaimie , Godwin Andrew K. , Jensen Roy A. , Kimler Bruce F. , Khan Qamar J. , Martin Miguel
Published: April 2023

Supplemental material contains names of participating institutions for the Spanish MMJ-CAR-2014-01 cohort, details on local guidelines for positive family history, tables depicting the relationship between pathological response and family history, pathological response and ER/PR status and univariate analysis of predictors of RCB 0+1. Supplemental Table 1. Pathological response and Family history of breast and ovarian cancer Supplemental Table 2. Pathological response by ER/PR Supplement Table 3. Predictors of RCB 0+1 on univariate analysis
Figure S2 from Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study
Authors: Hekman Marlène C.H. , Boerman Otto C. , de Weijert Mirjam , Bos Desirée L. , Oosterwijk Egbert , Langenhuijsen Hans F. , Mulders Peter F.A. , Rijpkema Mark
Published: April 2023

Photograph of an ex vivo tumorous kidney during a perfusion experiment. In this kidney, two renal arteries were connected to the perfusion system. During perfusion, the kidney was kept at 0-4 {degree sign}C and protected from light.
Supplementary Table S3 from Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer
Authors: Gyanchandani Rekha , Lin Yan , Lin Hui-Min , Cooper Kristine , Normolle Daniel P. , Brufsky Adam , Fastuca Michael , Crosson Whitney , Oesterreich Steffi , Davidson Nancy E. , Bhargava Rohit , Dabbs David J. , Lee Adrian V.
Published: April 2023

NanoString nCounter gene expression data for all GEPs
Supplementary Note from Mutational Signatures in Breast Cancer: The Problem at the DNA Level
Authors: Nik-Zainal Serena , Morganella Sandro
Published: April 2023

Supplementary Note
Supplementary Figure S3: Comparing mutational signatures from Mutational Signatures in Breast Cancer: The Problem at the DNA Level
Authors: Nik-Zainal Serena , Morganella Sandro
Published: April 2023

Supplementary Figure S3: Comparing mutational signatures
Supplementary Data from Synthetic Lethality Exploitation by an Anti–Trop-2-SN-38 Antibody–Drug Conjugate, IMMU-132, Plus PARP Inhibitors in BRCA1/2–wild-type Triple-Negative Breast Cancer
Authors: Cardillo Thomas M. , Sharkey Robert M. , Rossi Diane L. , Arrojo Roberto , Mostafa Ali A. , Goldenberg David M.
Published: April 2023

Supplemental methods, tables, and figures
Supplementary Table 1 from A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma
Authors: Zauderer Marjorie G. , Tsao Anne S. , Dao Tao , Panageas Katherine , Lai W. Victoria , Rimner Andreas , Rusch Valerie W. , Adusumilli Prasad S. , Ginsberg Michelle S. , Gomez Daniel , Rice David , Mehran Reza , Scheinberg David A. , Krug Lee M.
Published: April 2023

Includes peptide sequences for WT1 vaccine
Supplementary Figure 2 from A Randomized Phase II Trial of Adjuvant Galinpepimut-S, WT-1 Analogue Peptide Vaccine, After Multimodality Therapy for Patients with Malignant Pleural Mesothelioma
Authors: Zauderer Marjorie G. , Tsao Anne S. , Dao Tao , Panageas Katherine , Lai W. Victoria , Rimner Andreas , Rusch Valerie W. , Adusumilli Prasad S. , Ginsberg Michelle S. , Gomez Daniel , Rice David , Mehran Reza , Scheinberg David A. , Krug Lee M.
Published: April 2023

Data from an individual patient showing CD8 immune response to both native and heteroclitic peptides.
Supplementary Table 1, Supplementary Figures 1-4 from A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non–small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations
Authors: Yu Helena A. , Spira Alexander , Horn Leora , Weiss Jared , West Howard , Giaccone Giuseppe , Evans Tracey , Kelly Ronan J. , Desai Bhardwaj , Krivoshik Andrew , Moran Diarmuid , Poondru Srinivasu , Jie Fei , Aoyama Kouji , Keating Anne , Oxnard Geoffrey R.
Published: April 2023

Supplementary Table 1. Pharmacokinetic Parameters of ASP8273 from Patients in Dose-Escalation Cohort (PKAS) ; Supplementary Figure 1. Study design; Supplementary Figure 2. Quantitative change in EGFR cfDNA from baseline to Cycle 2 in escalating dose levels of ASP8273; Supplementary Figure 3. Changes in Levels of Mutant EGFR cfDNA (Activating or T790M) in Patients after One Cycle of Treatment with ASP8273 by Best Overall Response; Supplementary Figure 4. Identification of EGFR activating mutations, EGFR T790M and EGFR C797S in cfDNA from patients with Emergence of acquired resistance to ASP8273.
Supplementary Figure 4 from Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition
Authors: Sanmartín Elena , Muñoz Lisandra , Piqueras Marta , Sirerol J. Antoni , Berlanga Pablo , Cañete Adela , Castel Victoria , Font de Mora Jaime
Published: April 2023

Treatment with olaparib and temozolomide induces cell dead preferentially in IMR-32, NBL-S and LA-N-1 cell lines. Percentage of dead cells was determined at the indicated days by flow cytometry using LIVE/DEAD Fixable Near-IR Dead Cell Stain Kit (Invitrogen). Significance by t-test analysis was * p<0.001, ** p<0.01.
Revised supplementary file from Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor–Sensitive and -Resistant Chronic Myeloid Leukemia
Authors: Ben-Batalla Isabel , Erdmann Robert , Jørgensen Heather , Mitchell Rebecca , Ernst Thomas , von Amsberg Gunhild , Schafhausen Philippe , Velthaus Janna L. , Rankin Stephen , Clark Richard E. , Koschmieder Steffen , Schultze Alexander , Mitra Subir , Vandenberghe Peter , Brümmendorf Tim H. , Carmeliet Peter , Hochhaus Andreas , Pantel Klaus , Bokemeyer Carsten , Helgason G. Vignir , Holyoake Tessa L. , Loges Sonja
Published: April 2023

Supplementary material & methods, supplementary references, and supplementary figure legends
Supplementary Figure 6 from Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab
Authors: Krejcik Jakub , Frerichs Kris A. , Nijhof Inger S. , van Kessel Berris , van Velzen Jeroen F. , Bloem Andries C. , Broekmans Marloes E.C. , Zweegman Sonja , van Meerloo Johan , Musters René J.P. , Poddighe Pino J. , Groen Richard W.J. , Chiu Christopher , Plesner Torben , Lokhorst Henk M. , Sasser A. Kate , Mutis Tuna , van de Donk Niels W.C.J.
Published: April 2023

Transfer of surface membrane from UM9 cells to monocytes.
Supplementary Figure 5 from Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab
Authors: Krejcik Jakub , Frerichs Kris A. , Nijhof Inger S. , van Kessel Berris , van Velzen Jeroen F. , Bloem Andries C. , Broekmans Marloes E.C. , Zweegman Sonja , van Meerloo Johan , Musters René J.P. , Poddighe Pino J. , Groen Richard W.J. , Chiu Christopher , Plesner Torben , Lokhorst Henk M. , Sasser A. Kate , Mutis Tuna , van de Donk Niels W.C.J.
Published: April 2023

Monocytes take up AF488-labeled daratumumab-CD38 complexes from PKH-26-stained UM9 cells.
Supplementary Materials from Unsupervised Clustering of Quantitative Image Phenotypes Reveals Breast Cancer Subtypes with Distinct Prognoses and Molecular Pathways
Authors: Wu Jia , Cui Yi , Sun Xiaoli , Cao Guohong , Li Bailiang , Ikeda Debra M. , Kurian Allison W. , Li Ruijiang
Published: April 2023

Supplementary Methods Figure S1. The top ranked 25 imaging features in characterizing each imaging subtypes, after significance analysis of microarrays (SAM) analysis Figure S2. Validation of four selected quantitative imaging features (that are significant correlated with imaging subtypes in the discovery cohort) in the TCGA cohort. Table S1. Demographic data in imaging subtype discovery and validation cohorts. Table S2. Details of 110 Quantitative Image Features Extracted from DCE-MRI Table S3. Contingency table of the discovered imaging subtypes and intrinsic molecular subtypes in the validation cohort (TCGA, n=96). Table S4. Contingency table of the discovered imaging subtypes and clinicopathologic features including IHC expression of ER, PR, Her2 in the validation cohort (TCGA, n=96). Table S5. KEGG pathways significant associated (FDR <25%) with three imaging subtypes with Gene Set Enrichment Analysis (GSEA). Name ES NES
Supplementary Figure 4 from Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab
Authors: Krejcik Jakub , Frerichs Kris A. , Nijhof Inger S. , van Kessel Berris , van Velzen Jeroen F. , Bloem Andries C. , Broekmans Marloes E.C. , Zweegman Sonja , van Meerloo Johan , Musters René J.P. , Poddighe Pino J. , Groen Richard W.J. , Chiu Christopher , Plesner Torben , Lokhorst Henk M. , Sasser A. Kate , Mutis Tuna , van de Donk Niels W.C.J.
Published: April 2023

Daratumumab is transferred from UM9 cells to monocytes.
Supplementary legend from Shallow Whole Genome Sequencing on Circulating Cell-Free DNA Allows Reliable Noninvasive Copy-Number Profiling in Neuroblastoma Patients
Authors: Van Roy Nadine , Van Der Linden Malaïka , Menten Björn , Dheedene Annelies , Vandeputte Charlotte , Van Dorpe Jo , Laureys Geneviève , Renard Marleen , Sante Tom , Lammens Tim , De Wilde Bram , Speleman Frank , De Preter Katleen
Published: April 2023

Supplementary legend
Supplementary Figure 1 from Inhibition of Age-Related Therapy Resistance in Melanoma by Rosiglitazone-Mediated Induction of Klotho
Authors: Behera Reeti , Kaur Amanpreet , Webster Marie R. , Kim Suyeon , Ndoye Abibatou , Kugel Curtis H. , Alicea Gretchen M. , Wang Joshua , Ghosh Kanad , Cheng Phil , Lisanti Sofia , Marchbank Katie , Dang Vanessa , Levesque Mitchell , Dummer Reinhard , Xu Xiaowei , Herlyn Meenhard , Aplin Andrew E. , Roesch Alexander , Caino Cecilia , Altieri Dario C. , Weeraratna Ashani T.
Published: April 2023

Supplementary Figure 1
Supplementary Table S3 from Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle–Invasive Bladder Cancer Patients
Authors: Derré Laurent , Cesson Valérie , Lucca Ilaria , Cerantola Yannick , Valerio Massimo , Fritschi Urs , Vlamopoulos Yannis , Burruni Rodolfo , Legris Anne-Sophie , Dartiguenave Florence , Gharbi Dalila , Martin Virginie , Vaucher Laurent , Speiser Daniel E. , Romero Pedro , Jichlinski Patrice , Nardelli-Haefliger Denise
Published: April 2023

Characteristics of UroV1-A and UroV1-B cases
Supplementary Figure 1-2 from Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle–Invasive Bladder Cancer Patients
Authors: Derré Laurent , Cesson Valérie , Lucca Ilaria , Cerantola Yannick , Valerio Massimo , Fritschi Urs , Vlamopoulos Yannis , Burruni Rodolfo , Legris Anne-Sophie , Dartiguenave Florence , Gharbi Dalila , Martin Virginie , Vaucher Laurent , Speiser Daniel E. , Romero Pedro , Jichlinski Patrice , Nardelli-Haefliger Denise
Published: April 2023

Supplementary Figure S1: Treatment and sampling schedules; Supplementary Figure S2: Patients-flow diagram
Supplementary Figures and Tables from Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features
Authors: Lee Hyun-Sung , Jang Hee-Jin , Shah Rohan , Yoon David , Hamaji Masatsugu , Wald Ori , Lee Ju-Seog , Sugarbaker David J. , Burt Bryan M.
Published: April 2023

Supplementary Figures and Tables
Supplementary Figure 5 from Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study
Authors: Connolly Roisin M. , Li Huili , Jankowitz Rachel C. , Zhang Zhe , Rudek Michelle A. , Jeter Stacie C. , Slater Shannon A. , Powers Penny , Wolff Antonio C. , Fetting John H. , Brufsky Adam , Piekarz Richard , Ahuja Nita , Laird Peter W. , Shen Hui , Weisenberger Daniel J. , Cope Leslie , Herman James G. , Somlo George , Garcia Agustin A. , Jones Peter A. , Baylin Stephen B. , Davidson Nancy E. , Zahnow Cynthia A. , Stearns Vered
Published: April 2023

ER DNA methylation in hormone-resistant tumor biopsies.
Figure S2 from A Zebrafish Model Discovers a Novel Mechanism of Stromal Fibroblast-Mediated Cancer Metastasis
Authors: Liu Caifeng , Zhang Yunjian , Lim Sharon , Hosaka Kayoko , Yang Yunlong , Pavlova Tatiana , Alkasalias Twana , Hartman Johan , Jensen Lasse , Xing Xiaoming , Wang Xinsheng , Lu Yongtian , Nie Guohui , Cao Yihai
Published: April 2023

Mouse CAFs promote breast cancer metastasis
Dissemination of CAF-cancer cell complex from A Zebrafish Model Discovers a Novel Mechanism of Stromal Fibroblast-Mediated Cancer Metastasis
Authors: Liu Caifeng , Zhang Yunjian , Lim Sharon , Hosaka Kayoko , Yang Yunlong , Pavlova Tatiana , Alkasalias Twana , Hartman Johan , Jensen Lasse , Xing Xiaoming , Wang Xinsheng , Lu Yongtian , Nie Guohui , Cao Yihai
Published: April 2023

Video - Dissemination of CAF-cancer cell complex
supplementary figure legends from Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment
Authors: Yu Ming-Lung , Huang Chung-Feng , Yeh Ming-Lun , Tsai Pei-Chien , Huang Ching-I. , Hsieh Meng-Hsuan , Hsieh Ming-Yen , Lin Zu-Yau , Chen Shinn-Cherng , Huang Jee-Fu , Dai Chia-Yen , Chuang Wan-Long
Published: April 2023

Supplementary figure 1 legend. Risk of HCC in patients with or without SVR stratified by different age groups Supplementary figure 2 legend. Risk of HCC in patients with or without SVR stratified by different fibrotic stages
SFigure 5 from Macropinocytosis of Bevacizumab by Glioblastoma Cells in the Perivascular Niche Affects their Survival
Authors: Müller-Greven Gaëlle , Carlin Cathleen R. , Burgett Monica E. , Ahluwalia Manmeet S. , Lauko Adam , Nowacki Amy S. , Herting Cameron J. , Qadan Maha A. , Bredel Markus , Toms Steven A. , Lathia Justin D. , Hambardzumyan Dolores , Sarkaria Jann N. , Hamerlik Petra , Gladson Candece L.
Published: April 2023

Figure S5 shows co-localization of a fraction of the bevacizumab-VEGF complex with Rab4 and a fraction with LAMP1 in CD133+ GBM tumor cells.
Figure S2 from The c.1085A>G Genetic Variant of CSF1R Gene Regulates Tumor Immunity by Altering the Proliferation, Polarization, and Function of Macrophages
Authors: Yeh Yu-Min , Hsu Shan-Ju , Lin Peng-Chan , Hsu Keng-Fu , Wu Pei-Ying , Su Wu-Chou , Chang Jang-Yang , Shen Meng-Ru
Published: April 2023

The distribution of M1 and M2 macrophages in tumor specimens of endometrial and ovarian cancer.
Figure S3 from Hypoxia-Inducible PIM Kinase Expression Promotes Resistance to Antiangiogenic Agents
Authors: Casillas Andrea L. , Toth Rachel K. , Sainz Alva G. , Singh Neha , Desai Ankit A. , Kraft Andrew S. , Warfel Noel A.
Published: April 2023

Dose response curves for bevacizumab
Supplementary Table 1, Supplementary Figures 1-4 from TP53 Mutation and Its Prognostic Significance in Waldenstrom's Macroglobulinemia
Authors: Poulain Stéphanie , Roumier Christophe , Bertrand Elisabeth , Renneville Aline , Caillault-Venet Aurélie , Doye Emmanuelle , Geffroy Sandrine , Sebda Sheherazade , Nibourel Olivier , Nudel Morgane , Herbaux Charles , Renaud Loic , Tomowiak Cécile , Guidez Stéphanie , Tricot Sabine , Roche-Lestienne Catherine , Quesnel Bruno , Preudhomme Claude , Leleu Xavier
Published: April 2023

Table S1. Genomic characteristics of WM with TP53 aberration; Figure S1: Delineation of 17p minimal deleted region detected by SNP array in Waldenstrom's macroglobulinemia; Figure S2. (1) Nutlin-3a effects on WM cells. Impact of nutlin-3a (10 μM, 16h) on p53 targets (p53, p21, puma, MDM2) in different cell lines; Figure S3. (1) Ibrutinib did not increase expression of the p53 target. Impact of ibrutinib and nutlin 3a as reference drug on p53 targets (p53, p21, puma, MDM2) in different cell lines; Figure S4. Patterns of response to CP31398 and PrimaMet in WM. CP31398 and PrimaMet induces cell death independent of TP53 mutational status.
Supplemental Figure 5 from Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas
Authors: Choi Sung Hugh , Stuckey Daniel W. , Pignatta Sara , Reinshagen Clemens , Khalsa Jasneet Kaur , Roozendaal Nicolaas , Martinez-Quintanilla Jordi , Tamura Kaoru , Keles Erhan , Shah Khalid
Published: April 2023

mouse IFNÃŽÂ² inhibits growth of mouse GBM lines in vitro
Supplementary Methods, Supplementary Tables 1-2, Supplementary Figures 1-6 from Rapid and Continued T-Cell Differentiation into Long-term Effector and Memory Stem Cells in Vaccinated Melanoma Patients
Authors: Gannon Philippe O. , Baumgaertner Petra , Huber Alexandre , Iancu Emanuela M. , Cagnon Laurène , Abed Maillard Samia , Maby-El Hajjami Hélène , Speiser Daniel E. , Rufer Nathalie
Published: April 2023

Supplementary Table 1: Clinical characteristics of LUD00-0018 cohort; Supplementary Table 2. Patient characteristics; Supplementary Table 3: Adverse events; Supplementary Figure 1: Ex vivo frequencies of circulating Melan-A-specific CD8 T cell following peptide vaccinations; Supplementary Figure 2: Ex vivo characteriza9on of tumor--â€�specific CD8 stem cell--â€�like memory T cells before and after peptide vaccination; Supplementary Figure 3: Gating strategy for functional analyses following recognition of T2 target cells pulsed with native/EAA peptide; Supplementary Figure 4: Impact of peptide vaccinations on tumor antigen-specific CD8 T cell differentiation; Supplementary Figure 5: Gating strategy for single cell sorting of tumor-specific CD8 T cells following early and late native/EAA peptide vaccination time-points; Supplementary Figure 6: Ex vivo TRBV repertoire diversity and clonotype frequency of Melan-A-specific CD8 T cell subsets at early time-points after peptide vaccination.
Previously reported Fusobacterium in cancer tissues and patient prognosis from Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis
Authors: Yamamura Kensuke , Baba Yoshifumi , Nakagawa Shigeki , Mima Kosuke , Miyake Keisuke , Nakamura Kenichi , Sawayama Hiroshi , Kinoshita Koichi , Ishimoto Takatsugu , Iwatsuki Masaaki , Sakamoto Yasuo , Yamashita Yoichi , Yoshida Naoya , Watanabe Masayuki , Baba Hideo
Published: April 2023

Previously reported Fusobacterium in cancer tissues and patient prognosis
Supplementary Figures from RETRACTED: KMT2C Mutations in Diffuse-Type Gastric Adenocarcinoma Promote Epithelial-to-Mesenchymal Transition
Authors: Cho Soo-Jeong , Yoon Changhwan , Lee Jun Ho , Chang Kevin K. , Lin Jian-xian , Kim Young-Ho , Kook Myeong-Cherl , Aksoy Bülent Arman , Park Do Joong , Ashktorab Hassan , Smoot Duane T. , Schultz Nikolaus , Yoon Sam S.
Published: April 2023

Supplementary Figures S1-S5
Figure S4 from Etk Interaction with PFKFB4 Modulates Chemoresistance of Small-cell Lung Cancer by Regulating Autophagy
Authors: Wang Qiongyao , Zeng Fanrui , Sun Yanqin , Qiu Qianqian , Zhang Jian , Huang Weimei , Huang Jie , Huang Xiaomin , Guo Linlang
Published: April 2023

Figure S4. Modulated expression of PFKFB4 in SCLC cells.
Supplementary Table 2 from Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma
Authors: Chicard Mathieu , Colmet-Daage Leo , Clement Nathalie , Danzon Adrien , Bohec Mylène , Bernard Virginie , Baulande Sylvain , Bellini Angela , Deveau Paul , Pierron Gaëlle , Lapouble Eve , Janoueix-Lerosey Isabelle , Peuchmaur Michel , Corradini Nadège , Defachelles Anne Sophie , Valteau-Couanet Dominique , Michon Jean , Combaret Valérie , Delattre Olivier , Schleiermacher Gudrun
Published: April 2023

Table S2 : detailed description of time points for plasma sampling.
Figure S2 from Etk Interaction with PFKFB4 Modulates Chemoresistance of Small-cell Lung Cancer by Regulating Autophagy
Authors: Wang Qiongyao , Zeng Fanrui , Sun Yanqin , Qiu Qianqian , Zhang Jian , Huang Weimei , Huang Jie , Huang Xiaomin , Guo Linlang
Published: April 2023

Figure S2. Etk modulates the expression of PFKFB4 in SCLC.
Figure S2 from Long Noncoding RNA LINC01234 Functions as a Competing Endogenous RNA to Regulate CBFB Expression by Sponging miR-204-5p in Gastric Cancer
Authors: Chen Xin , Chen Zhenyao , Yu Shanxun , Nie Fengqi , Yan Shuai , Ma Pei , Chen Qinnan , Wei Chenchen , Fu Hangjiang , Xu Tianwei , Ren Shengnan , Sun Ming , Wang Zhaoxia
Published: April 2023

Effect of miR-204-5p on GC cells proliferation.
Table S5 from Chemical Profiling of Primary Mesothelioma Cultures Defines Subtypes with Different Expression Profiles and Clinical Responses
Authors: Schunselaar Laurel M. , Quispel-Janssen Josine M.M.F. , Kim Yongsoo , Alifrangis Constantine , Zwart Wilbert , Baas Paul , Neefjes Jacques
Published: April 2023

Table S5. List of differential expressed genes. Symbol and gene name of differential expressed genes between the responder and the non-responder groups. 57 DEGs could not be identified by Ingenuity pathway analysis.
Figure S1 from Long Noncoding RNA LINC01234 Functions as a Competing Endogenous RNA to Regulate CBFB Expression by Sponging miR-204-5p in Gastric Cancer
Authors: Chen Xin , Chen Zhenyao , Yu Shanxun , Nie Fengqi , Yan Shuai , Ma Pei , Chen Qinnan , Wei Chenchen , Fu Hangjiang , Xu Tianwei , Ren Shengnan , Sun Ming , Wang Zhaoxia
Published: April 2023

Effect of LINC01234 on GC cells apoptosis and tumor growth
Supplementary information from The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression
Authors: Huang Lu , Malu Shruti , McKenzie Jodi A. , Andrews Miles C. , Talukder Amjad H. , Tieu Trang , Karpinets Tatiana , Haymaker Cara , Forget Marie-Andrée , Williams Leila J. , Wang Zhe , Mbofung Rina M. , Wang Zhi-Qiang , Davis Richard Eric , Lo Roger S. , Wargo Jennifer A. , Davies Michael A. , Bernatchez Chantale , Heffernan Timothy , Amaria Rodabe N. , Korkut Anil , Peng Weiyi , Roszik Jason , Lizée Gregory , Woodman Scott E. , Hwu Patrick
Published: April 2023

Supplementary figure and table legends
Figure S3 from Chemical Profiling of Primary Mesothelioma Cultures Defines Subtypes with Different Expression Profiles and Clinical Responses
Authors: Schunselaar Laurel M. , Quispel-Janssen Josine M.M.F. , Kim Yongsoo , Alifrangis Constantine , Zwart Wilbert , Baas Paul , Neefjes Jacques
Published: April 2023

Fig S3. Dose-response curves of single agents and combination depicted for the differently responding subgroups. Dose-response curves of Fig. 2 separated to single agents and combinations are depicted for a responder (A), a non responder (B) and an intermediate responder (C). Explanation for the subgroup definition is depicted next to the dose-response curves.
Supplementary from RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells
Authors: Yang Xiaosong , Pan You , Qiu Zhaojun , Du Zhanwen , Zhang Yao , Fa Pengyan , Gorityala Shashank , Ma Shanhuai , Li Shunqiang , Chen Ceshi , Wang Hongbing , Xu Yan , Yan Chunhong , Ruth Keri , Ma Zhefu , Zhang Junran
Published: April 2023

Supplementary Table S1. Association between RNF126 protein expression and clinicopathological parameters in invasive BC. Supplementary Table S2. RNF126 expression and clinicopathologic variables of invasive BC Supplementary Fig. S1. Cell cycle distribution. Supplementary Fig. S2. RNF126 controls CHK1 expression via a direct interaction with E2F1. Supplementary Fig.S3. RNF126 facilitated Cyclin E expression. Supplementary Fig. S4. CHK1 inhibition decreased cell numbers at a greater level in parental cells, compared to cells depleted of RNF126. Supplementary Fig.S5. CHK1 inhibition promoted cell apoptosis and blocked mitotic entry, particularly in cells expressing RNF126. Supplementary Fig.S6. ATR inhibition decreased parental cell numbers and increased replication stress at a greater level, compared to cells depleted of RNF126. Supplementary Fig. S7. CHK1 inhibition upregulates replication stress, particularly in cells with intact RNF126. Supplementary Fig.S8 Representative images of replication tracks from MCF7 cells treated with or without LY2603618 (5 μM).
Supplementary Tables from RIP1–HAT1–SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer
Authors: Carafa Vincenzo , Nebbioso Angela , Cuomo Francesca , Rotili Dante , Cobellis Gilda , Bontempo Paola , Baldi Alfonso , Spugnini Enrico P. , Citro Gennaro , Chambery Angela , Russo Rosita , Ruvo Menotti , Ciana Paolo , Maravigna Luca , Shaik Jani , Radaelli Enrico , De Antonellis Pasquale , Tarantino Domenico , Pirolli Adele , Ragno Rino , Zollo Massimo , Stunnenberg Hendrik G. , Mai Antonello , Altucci Lucia
Published: April 2023

Supplementary Tables
On line Materials and Methods from RIP1–HAT1–SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer
Authors: Carafa Vincenzo , Nebbioso Angela , Cuomo Francesca , Rotili Dante , Cobellis Gilda , Bontempo Paola , Baldi Alfonso , Spugnini Enrico P. , Citro Gennaro , Chambery Angela , Russo Rosita , Ruvo Menotti , Ciana Paolo , Maravigna Luca , Shaik Jani , Radaelli Enrico , De Antonellis Pasquale , Tarantino Domenico , Pirolli Adele , Ragno Rino , Zollo Massimo , Stunnenberg Hendrik G. , Mai Antonello , Altucci Lucia
Published: April 2023

On line Materials and Methods
Supplementary Figure S1 from Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases
Authors: Chan Nancy , Willis Amy , Kornhauser Naomi , Ward Maureen M. , Lee Sharrell B. , Nackos Eleni , Seo Bo Ri , Chuang Ellen , Cigler Tessa , Moore Anne , Donovan Diana , Vallee Cobham Marta , Fitzpatrick Veronica , Schneider Sarah , Wiener Alysia , Guillaume-Abraham Jessica , Aljom Elnaz , Zelkowitz Richard , Warren J. David , Lane Maureen E. , Fischbach Claudia , Mittal Vivek , Vahdat Linda
Published: April 2023

This is the schema of the clinical study design. This is a Phase 2 trial of TM in breast cancer at high risk of recurrence. Eligible patients received TM for 2 years to achieve a target CP level of < 17 mg/dL. Primary endpoint was effect on VEGFR2+ EPCS.
Suppl. Table 2 from Clinical Significance of PD-L1+ Exosomes in Plasma of Head and Neck Cancer Patients
Authors: Theodoraki Marie-Nicole , Yerneni Saigopalakrishna S. , Hoffmann Thomas K. , Gooding William E. , Whiteside Theresa L.
Published: April 2023

Treatment regimens of patients with NED
Supplementary Figures 1-2, Supplementary Tables 1-2 from Multivalent Binding and Biomimetic Cell Rolling Improves the Sensitivity and Specificity of Circulating Tumor Cell Capture
Authors: Myung Ja Hye , Eblan Michael J. , Caster Joseph M. , Park Sin-Jung , Poellmann Michael J. , Wang Kyle , Tam Kevin A. , Miller Seth M. , Shen Colette , Chen Ronald C. , Zhang Tian , Tepper Joel E. , Chera Bhishamjit S. , Wang Andrew Z. , Hong Seungpyo
Published: April 2023

Table S1. Clinical and demographic characteristics of recruited cancer patients; Table S2. Demographic characteristics of recruited healthy donors; Figure S1. Reproducibility confirmation of CapioCyte-D by testing duplicated blood samples from three cancer patients (A-C) using separately prepared capture surfaces (slides 1 and 2); Figure S2. A comparison of the captured epithelial cell number from two healthy donor groups with different age ranges (under 35 years vs. above 50 years).
Supplementary Material and Method from Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer
Authors: Chen Ying , Camacho Sandra Catalina , Silvers Thomas R. , Razak Albiruni R.A. , Gabrail Nashat Y. , Gerecitano John F. , Kalir Eva , Pereira Elena , Evans Brad R. , Ramus Susan J. , Huang Fei , Priedigkeit Nolan , Rodriguez Estefania , Donovan Michael , Khan Faisal , Kalir Tamara , Sebra Robert , Uzilov Andrew , Chen Rong , Sinha Rileen , Halpert Richard , Billaud Jean-Noel , Shacham Sharon , McCauley Dilara , Landesman Yosef , Rashal Tami , Kauffman Michael , Mirza Mansoor R. , Mau-Sørensen Morten , Dottino Peter , Martignetti John A.
Published: April 2023

Supplementary Material and Method
Supplementary Figure Legend from Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer
Authors: Chen Ying , Camacho Sandra Catalina , Silvers Thomas R. , Razak Albiruni R.A. , Gabrail Nashat Y. , Gerecitano John F. , Kalir Eva , Pereira Elena , Evans Brad R. , Ramus Susan J. , Huang Fei , Priedigkeit Nolan , Rodriguez Estefania , Donovan Michael , Khan Faisal , Kalir Tamara , Sebra Robert , Uzilov Andrew , Chen Rong , Sinha Rileen , Halpert Richard , Billaud Jean-Noel , Shacham Sharon , McCauley Dilara , Landesman Yosef , Rashal Tami , Kauffman Michael , Mirza Mansoor R. , Mau-Sørensen Morten , Dottino Peter , Martignetti John A.
Published: April 2023

Supplementary Figure Legend
Suppl Tables I and II from Development of a Function-Blocking Antibody Against Fibulin-3 as a Targeted Reagent for Glioblastoma
Authors: Nandhu Mohan S. , Behera Prajna , Bhaskaran Vivek , Longo Sharon L. , Barrera-Arenas Lina M. , Sengupta Sadhak , Rodriguez-Gil Diego J. , Chiocca E. Antonio , Viapiano Mariano S.
Published: April 2023

Supplemental Table I: Antibodies used for Western blotting and immunohistochemistry (IHC); Supplemental Table II: Sequences used for qRT-PCR primers.
Supplementary Figure 1c from Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib
Authors: Kraft Ira L. , Akshintala Srivandana , Zhu Yuelin , Lei Haiyan , Derse-Anthony Claudia , Dombi Eva , Steinberg Seth M. , Lodish Maya , Waguespack Steven G. , Kapustina Oxana , Fox Elizabeth , Balis Frank M. , Merino Maria J. , Meltzer Paul S. , Glod John W. , Shern Jack F. , Widemann Brigitte C.
Published: April 2023

Patients #2, #5, #10, #11, #13, #15, and #16 experienced durable SD or PR during the follow up period. Calcitonin and CEA are shown as percent change from baseline at the start of vandetanib therapy (left y-axis). Tumor size is the sum of longest diameter of lesions per RECISTv1.0 (right y-axis).
Supplementary Materials and Methods/figure legend from Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells
Authors: Gammaitoni Loretta , Giraudo Lidia , Macagno Marco , Leuci Valeria , Mesiano Giulia , Rotolo Ramona , Sassi Francesco , Sanlorenzo Martina , Zaccagna Alessandro , Pisacane Alberto , Senetta Rebecca , Cangemi Michela , Cattaneo Giulia , Martin Valentina , Coha Valentina , Gallo Susanna , Pignochino Ymera , Sapino Anna , Grignani Giovanni , Carnevale-Schianca Fabrizio , Aglietta Massimo , Sangiolo Dario
Published: April 2023

DNA extraction and Sanger Sequencing In vivo Limiting Dilution Assay Cell growth inhibition assay Analysis of LV.Oct4.eGFP integration in eGFP positive and negative cell fractions
Supplemental Methods from Protein Kinase C Epsilon Is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia
Authors: Di Marcantonio Daniela , Martinez Esteban , Sidoli Simone , Vadaketh Jessica , Nieborowska-Skorska Margaret , Gupta Anushk , Meadows Jake M. , Ferraro Francesca , Masselli Elena , Challen Grant A. , Milsom Michael D. , Scholl Claudia , Fröhling Stefan , Balachandran Siddharth , Skorski Tomasz , Garcia Benjamin A. , Mirandola Prisco , Gobbi Giuliana , Garzon Ramiro , Vitale Marco , Sykes Stephen M.
Published: April 2023

Supplemental Methods
Suplementary fig 3 from Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent
Authors: Piulats Josep M. , Vidal August , García-Rodríguez Francisco J. , Muñoz Clara , Nadal Marga , Moutinho Catia , Martínez-Iniesta María , Mora Josefina , Figueras Agnés , Guinó Elisabet , Padullés Laura , Aytés Àlvaro , Molleví David G. , Puertas Sara , Martínez-Fernández Carmen , Castillo Wilmar , Juliachs Merce , Moreno Victor , Muñoz Purificación , Stefanovic Milica , Pujana Miguel A. , Condom Enric , Esteller Manel , Germà Josep R. , Capella Gabriel , Farré Lourdes , Morales Albert , Viñals Francesc , García-del-Muro Xavier , Cerón Julián , Villanueva Alberto
Published: April 2023

Representative recurrent imbalanced regions in different orthoxenografts with acquired CDDP resistance